The largest COVID vaccine study to date has identified some risks associated with the shot. Researchers from the Global Vaccine Data Network (GVDN) in New Zealand analyzed 99 million people who ...
Findings from a phase I trial (NCT04183166) evaluating TG4050, a neoantigen therapeutic vaccine, in patients with operable, ...
Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice. The vaccine ...
The content on this page is provided for reference purposes only. This content has not been altered or updated since 22 December 2022 The development and distribution of an effective and safe vaccine ...
Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results